New stent aims to prevent stroke in patients with clogged neck arteries

NCT ID NCT06365697

Ongoing Disease control Sponsor: Ton-Bridge Medical Tech. Co., Ltd Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new device called the Ton-bridge carotid stent for treating carotid artery stenosis, a condition where the main arteries in the neck become narrowed, raising stroke risk. Researchers will compare it to a standard stent in 188 patients aged 18-80 who have significant blockage. The main goal is to see if the new stent is as safe and effective, looking at major problems like death, stroke, or heart attack within 30 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Ton-bridge carotid stent (a mesh tube placed in the neck artery to keep it open)
What this could lead to: If successful, this could offer a safe and effective new option for treating narrowed carotid arteries, potentially reducing the risk of stroke.
What could go wrong: This is a mid-stage trial with only 188 participants, so results may not apply to everyone. There are standard risks like stroke, heart attack, or death from the procedure itself.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CAROTID ARTERY STENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

carotid stenosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CAROTID ARTERY STENOSIS

Contacts and locations

Locations

Central Hospital Affiliated to Shangdong First Medical University

Jinan, Shangdong, China
Linyi People's Hospital

Linyi, Shandong, China
Lishui Central Hospital

Lishui, Zhejiang, China
Qingdao Central Hospital

Qingdao, Shandong, China
The Affiliated Hospital of Qingdao University

Qingdao, Shandong, China
The People's Hospital of Liaoning Province

Shenyang, Liaoning, China
Xuanwu Hospital, Capital Medical University

Beijing, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.